Get free alertsFree alerts
Menu

Biologic, Biosimilar’s and Methotrexate Injections

Closes in 2 days.

BuyerThe Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
WhereScotland
Value£334.9m
Contract lengthabout 2 years
Deadline21 Oct 2026
Published21 Sep 2026
SectorMedical equipment and pharmaceuticals
Suitable for small firmsNot stated
SourceFind a Tender

Read the official notice

What the buyer says

Supply of Biologics, Biosimilars and Methotrexate Injections to NHS Scotland.

Lots (13)

You can usually bid for one lot or several. Check the tender documents for the rules.

  1. Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Device
  2. Infliximab Subcutaneous Injection
  3. Methotrexate (25mg/1ml concentration) Pre-Filled Self Injection Syringe
  4. Methotrexate (50mg/1ml concentration) Pre-Filled Self Injection Device
  5. Methotrexate (50mg/1ml concentration) Pre-Filled Syringe
  6. Adalimumab
  7. Etanercept
  8. Golimumab
  9. Infliximab Intravenous Infusion
  10. Omalizumab
  11. Tocilizumab
  12. Ustekinumab
  13. Tildrakizumab

More open contracts from The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)

The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland): past medical equipment and pharmaceuticals awards

36 awards in our data, typical value £4.3m.

Similar open contracts